Nanobodies: The "Magic Bullets" in therapeutics, drug delivery and diagnostics
Antibodies represent a well-established class of clinical diagnostics for medical applications as well as essential research and biotechnological tools. Although both polyclonal and monoclonal antibodies are indispensable reagents in basic research and diagnostics but both of them have their limitat...
Uloženo v:
| Vydáno v: | Human antibodies Ročník 28; číslo 1; s. 29 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Netherlands
2020
|
| Témata: | |
| ISSN: | 1875-869X, 1875-869X |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Antibodies represent a well-established class of clinical diagnostics for medical applications as well as essential research and biotechnological tools. Although both polyclonal and monoclonal antibodies are indispensable reagents in basic research and diagnostics but both of them have their limitations. Hence, there is urgent need to develop strategies aimed at production of alternative scaffolds and recombinant antibodies of smaller dimensions that could be easily produced, selected and manipulated. Unlike conventional antibodies, members of Camelidae and sharks produce antibodies composed only of heavy chains with small size, high solubility, thermal stability, refolding capacity and good tissue penetration in vivo. The discovery of these naturally occurring antibodies having only heavy-chain in Camelidae family and their further development into small recombinant nanobodies represents an attractive alternative in drug delivery, diagnostics and imaging. Nanobody derivatives are soluble, stable, versatile, have unique refolding capacities, reduced aggregation tendencies and high-target binding capabilities. They can be genetically customized to target enzymes, transmembrane proteins or molecular interactions. Their ability to recognize recessed antigenic sites has been attributed to their smaller size and the ability of the extended CDR3 loop to quickly penetrate into such epitopes. With the advent of molecular engineering and phage display technology, they can be of potential use in molecular imaging, drug delivery and therapeutics for several major diseases. In this review we present the recent advances in nanobodies for modulating immune functions, for targeting cancers, viruses, toxins and microbes as well as their utility as diagnostic and biosensor tools. |
|---|---|
| AbstractList | Antibodies represent a well-established class of clinical diagnostics for medical applications as well as essential research and biotechnological tools. Although both polyclonal and monoclonal antibodies are indispensable reagents in basic research and diagnostics but both of them have their limitations. Hence, there is urgent need to develop strategies aimed at production of alternative scaffolds and recombinant antibodies of smaller dimensions that could be easily produced, selected and manipulated. Unlike conventional antibodies, members of Camelidae and sharks produce antibodies composed only of heavy chains with small size, high solubility, thermal stability, refolding capacity and good tissue penetration in vivo. The discovery of these naturally occurring antibodies having only heavy-chain in Camelidae family and their further development into small recombinant nanobodies represents an attractive alternative in drug delivery, diagnostics and imaging. Nanobody derivatives are soluble, stable, versatile, have unique refolding capacities, reduced aggregation tendencies and high-target binding capabilities. They can be genetically customized to target enzymes, transmembrane proteins or molecular interactions. Their ability to recognize recessed antigenic sites has been attributed to their smaller size and the ability of the extended CDR3 loop to quickly penetrate into such epitopes. With the advent of molecular engineering and phage display technology, they can be of potential use in molecular imaging, drug delivery and therapeutics for several major diseases. In this review we present the recent advances in nanobodies for modulating immune functions, for targeting cancers, viruses, toxins and microbes as well as their utility as diagnostic and biosensor tools. Antibodies represent a well-established class of clinical diagnostics for medical applications as well as essential research and biotechnological tools. Although both polyclonal and monoclonal antibodies are indispensable reagents in basic research and diagnostics but both of them have their limitations. Hence, there is urgent need to develop strategies aimed at production of alternative scaffolds and recombinant antibodies of smaller dimensions that could be easily produced, selected and manipulated. Unlike conventional antibodies, members of Camelidae and sharks produce antibodies composed only of heavy chains with small size, high solubility, thermal stability, refolding capacity and good tissue penetration in vivo. The discovery of these naturally occurring antibodies having only heavy-chain in Camelidae family and their further development into small recombinant nanobodies represents an attractive alternative in drug delivery, diagnostics and imaging. Nanobody derivatives are soluble, stable, versatile, have unique refolding capacities, reduced aggregation tendencies and high-target binding capabilities. They can be genetically customized to target enzymes, transmembrane proteins or molecular interactions. Their ability to recognize recessed antigenic sites has been attributed to their smaller size and the ability of the extended CDR3 loop to quickly penetrate into such epitopes. With the advent of molecular engineering and phage display technology, they can be of potential use in molecular imaging, drug delivery and therapeutics for several major diseases. In this review we present the recent advances in nanobodies for modulating immune functions, for targeting cancers, viruses, toxins and microbes as well as their utility as diagnostic and biosensor tools.Antibodies represent a well-established class of clinical diagnostics for medical applications as well as essential research and biotechnological tools. Although both polyclonal and monoclonal antibodies are indispensable reagents in basic research and diagnostics but both of them have their limitations. Hence, there is urgent need to develop strategies aimed at production of alternative scaffolds and recombinant antibodies of smaller dimensions that could be easily produced, selected and manipulated. Unlike conventional antibodies, members of Camelidae and sharks produce antibodies composed only of heavy chains with small size, high solubility, thermal stability, refolding capacity and good tissue penetration in vivo. The discovery of these naturally occurring antibodies having only heavy-chain in Camelidae family and their further development into small recombinant nanobodies represents an attractive alternative in drug delivery, diagnostics and imaging. Nanobody derivatives are soluble, stable, versatile, have unique refolding capacities, reduced aggregation tendencies and high-target binding capabilities. They can be genetically customized to target enzymes, transmembrane proteins or molecular interactions. Their ability to recognize recessed antigenic sites has been attributed to their smaller size and the ability of the extended CDR3 loop to quickly penetrate into such epitopes. With the advent of molecular engineering and phage display technology, they can be of potential use in molecular imaging, drug delivery and therapeutics for several major diseases. In this review we present the recent advances in nanobodies for modulating immune functions, for targeting cancers, viruses, toxins and microbes as well as their utility as diagnostic and biosensor tools. |
| Author | Mir, Manzoor A Sheikh, Bashir Ahmad Mehraj, Umar Hamdani, Syed Suhail |
| Author_xml | – sequence: 1 givenname: Manzoor A surname: Mir fullname: Mir, Manzoor A – sequence: 2 givenname: Umar surname: Mehraj fullname: Mehraj, Umar – sequence: 3 givenname: Bashir Ahmad surname: Sheikh fullname: Sheikh, Bashir Ahmad – sequence: 4 givenname: Syed Suhail surname: Hamdani fullname: Hamdani, Syed Suhail |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31322555$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMFLwzAYxYNMdE4v_gESdvJgtfmyNIm3bagT5rxM8FbS5FsXaNPZtML-exUneHoP3u-9wzsjg9AEJOSSpbccOL9bTGcJ0ynX6REZMiVFojL9PvjnT8gpZxxACDEkq5UJTdE4j_GerrdIxy-m9JbO-qrCLo6pD7TbYmt22Hfexhvq2r6kDiv_ie2emuCo86YMTfyJz8nxxlQRLw46Im-PD-v5Ilm-Pj3Pp8vEclBdYlLGDVrgEztBlmnnhN4gasuklU4agdqBUswxpjRowQWDghlbyHSTSS5hRK5_d3dt89Fj7PLaR4tVZQI2fcwBMgYqFd-9Ebk6oH1Ro8t3ra9Nu8__PoAv-ftbFw |
| CitedBy_id | crossref_primary_10_1007_s12032_022_01779_9 crossref_primary_10_1016_j_microc_2025_114083 crossref_primary_10_3390_nano11123360 crossref_primary_10_3390_md21090496 crossref_primary_10_1007_s12032_022_01811_y crossref_primary_10_1039_D5RA03102H crossref_primary_10_3892_ijmm_2023_5336 crossref_primary_10_1038_s41598_022_27161_3 crossref_primary_10_1007_s12033_023_00700_7 crossref_primary_10_3233_HAB_210443 crossref_primary_10_1007_s12250_021_00436_1 crossref_primary_10_1016_j_pep_2022_106094 crossref_primary_10_1002_art_42273 crossref_primary_10_1089_cbr_2020_3941 crossref_primary_10_1016_j_bbrc_2024_150956 crossref_primary_10_1093_mr_roac126 crossref_primary_10_3389_fmed_2023_1135541 crossref_primary_10_1186_s13075_023_03036_4 crossref_primary_10_1007_s12032_022_01748_2 crossref_primary_10_3390_ijms24031905 crossref_primary_10_1128_Spectrum_00915_21 crossref_primary_10_3233_HAB_200436 crossref_primary_10_1002_wnan_1697 crossref_primary_10_3389_fphar_2024_1510806 crossref_primary_10_3390_vetsci11110533 crossref_primary_10_3390_cells9030741 crossref_primary_10_3390_pharmaceutics13121984 crossref_primary_10_1016_j_drudis_2023_103550 crossref_primary_10_1016_j_intimp_2025_115368 crossref_primary_10_1089_cbr_2021_0389 crossref_primary_10_1016_j_addr_2021_113940 crossref_primary_10_1002_mco2_60 crossref_primary_10_1021_acschembio_5c00329 crossref_primary_10_1007_s00432_022_04515_y crossref_primary_10_1016_j_molimm_2023_09_005 crossref_primary_10_3389_fimmu_2021_690742 crossref_primary_10_1093_mr_roac119 |
| ContentType | Journal Article |
| DBID | NPM 7X8 |
| DOI | 10.3233/HAB-190390 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 1875-869X |
| ExternalDocumentID | 31322555 |
| Genre | Journal Article |
| GroupedDBID | NPM 7X8 |
| ID | FETCH-LOGICAL-c328t-a013aec234c4e169dd59fee9c17c7d7a5e9d2881d11892953512b1acb70f67372 |
| IEDL.DBID | 7X8 |
| ISSN | 1875-869X |
| IngestDate | Thu Jul 10 18:38:43 EDT 2025 Thu Jan 02 22:59:51 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | diagnostics chimeric immunoaffinity chromatography site directed mutagenesis cancer drug delivery nanobody Recombinant antibodies humanized antibodies |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c328t-a013aec234c4e169dd59fee9c17c7d7a5e9d2881d11892953512b1acb70f67372 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 31322555 |
| PQID | 2261280551 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2261280551 pubmed_primary_31322555 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-00-00 |
| PublicationDateYYYYMMDD | 2020-01-01 |
| PublicationDate_xml | – year: 2020 text: 2020-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Human antibodies |
| PublicationTitleAlternate | Hum Antibodies |
| PublicationYear | 2020 |
| Score | 2.394184 |
| SecondaryResourceType | review_article |
| Snippet | Antibodies represent a well-established class of clinical diagnostics for medical applications as well as essential research and biotechnological tools.... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 29 |
| Title | Nanobodies: The "Magic Bullets" in therapeutics, drug delivery and diagnostics |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31322555 https://www.proquest.com/docview/2261280551 |
| Volume | 28 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFB7UevDiglvdGItHhyaZLDNeRMTipaEHhdzCrFKQpG1awX_vm0mKXgTBSy4hMLy85XvLfA-hG-FhtLbEZJEiMVdgc1SCXQUmsSp2nSLpl01kec6Kgk-6glvTjVWufaJ31LpWrkY-jBzXFQsgwN_P5sRtjXLd1W6FxibqUYAyTquzwt9-AxhOWMqLlpGURpQOwRoIhD_Kg9_RpI8qo73_nmcf7XZ4Ej-0CnCANkx1iHLwmbWs3YDgHQZFwIOxAA-HW67tZoCnFf5x8aq5xXqxesPavLspjU8sKo11O4PnXh-h19HTy-Mz6RYnEEUjtiQCcJ0wKqKxik2Ycq0Tbo3hKsxUpjORGK4jBkgVsguARwmFqC9DoWQWWL-35hhtVXVlThG2MeAVJXXKZBrrFPSO2RTiqlGxVSy0fXS9Fk8Jium6DaIy9aopvwXURyetjMtZy6BROr5IyGWSsz98fY52Ipfj-rLHBepZMEtzibbVx3LaLK78H4dnPhl_AYzit8c |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanobodies%3A+The+%22Magic+Bullets%22+in+therapeutics%2C+drug+delivery+and+diagnostics&rft.jtitle=Human+antibodies&rft.au=Mir%2C+Manzoor+A&rft.au=Mehraj%2C+Umar&rft.au=Sheikh%2C+Bashir+Ahmad&rft.au=Hamdani%2C+Syed+Suhail&rft.date=2020-01-01&rft.eissn=1875-869X&rft.volume=28&rft.issue=1&rft.spage=29&rft_id=info:doi/10.3233%2FHAB-190390&rft_id=info%3Apmid%2F31322555&rft_id=info%3Apmid%2F31322555&rft.externalDocID=31322555 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1875-869X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1875-869X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1875-869X&client=summon |